Gain practical insight into how adeno-associated virus (AAV) production can be scaled from development studies to manufacturing-relevant scale while mainta...

The gene therapy landscape is expanding rapidly, but manufacturing costs remain the primary barrier to commercial and clinical accessibility. Therapy devel...

Ready to accelerate your cell therapy development? Lipid nanoparticles (LNPs) are rapidly emerging as a versatile and scalable delivery platform for cell ...

In this webinar, we explore key considerations and best practices for scaling AAV production, including selecting a transient transfection cell line and sc...

Unlock advanced approaches to scalable plasmid DNA (pDNA) production in this on-demand webinar, designed for CDMOs and Translational Centers seeking to enh...

Cell and gene therapies are entering a transformative era driven by the need for scalable, cost-effective, and safe gene editing and delivery technologies....

When it comes to cell therapy manufacturing, you’re not just in production. You’re crafting hope for millions awaiting these breakthrough treatments. And e...

Cell therapy starting material varies significantly, presenting challenges in maintaining a standardized and reproducible manufacturing process. With the r...

Looking to streamline your CAR T cell process? Discover how lipid nanoparticles (LNP) deliver base editing tools to generate fratricide-resistant CD45-edit...

Delivering nucleic acids using lipid nanoparticles (LNP) to target cells has tremendous potential to enable new cell and gene therapies. In this webinar, w...